![]() ExeVir Bio ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses. | ||
Founding Date | Founding Date 2019 | Founding Date 2020 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Gent, BE HQ |
Employees | Employees 1534% decrease | Employees 1611% decrease |
Funding | ||
Latest funding round | Latest funding round $ 44.5m (about 7 years ago) | Latest funding round $ 23m (about 5 years ago) |
Total funding raised | Total funding raised $ 44.5m | Total funding raised $ 50m |

ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.
View company